Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.84
Delayed Data
As of Apr 19
 -0.02 / -0.41%
Today’s Change
3.92
Today|||52-Week Range
8.38
+4.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues11.8M15.1M15.0M18.7M
 
 
 
 
 
Cost of Goods Sold5.1M5.0M6.7M8.0M
 
 
 
 
 
Depreciation And Amortization229.0K230.0K230.0K248.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.5M9.9M8.1M10.4M
 
 
 
 
 
General Expenses29.6M33.8M31.8M41.4M
 
 
 
 
 
Research And Development6.8M9.0M9.3M12.6M
 
 
 
 
 
Total Operating Expenses34.9M39.0M38.7M49.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.1M-23.9M-23.7M-31.0M
 
 
 
 
 
Extraordinary Credit0.00225.0K0.004.8M
 
 
 
Interest Expense On Debt0.0063.0M0.000.00
 
 
Other Expenses-3.0K-5.0K1.0K-4.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.0M-86.5M-23.5M-30.7M
 
 
 
 
 
Income Taxes-20.0K-20.0K-20.0K-295.0K
 
 
 
 
 
Net Income-23.0M-86.5M-23.5M-30.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS107.1M112.6M119.0M119.2M
 
 
 
 
 
Shares To Calculate EPS Diluted107.1M112.6M119.0M119.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.77-$0.20-$0.26
 
 
 
 
 
EPS Diluted-$0.21-$0.77-$0.20-$0.26